Cargando…
Immunotherapy in colorectal cancer: Available clinical evidence, challenges and novel approaches
In contrast to other tumor types, immunotherapy has not yet become a relevant part of the treatment landscape of unselected colorectal cancer. Beside the small subgroup of deficient mismatch repair or microsatellite instable tumors (about 5%) as a surrogate for high mutational burden and subsequentl...
Autores principales: | Tintelnot, Joseph, Stein, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689806/ https://www.ncbi.nlm.nih.gov/pubmed/31413527 http://dx.doi.org/10.3748/wjg.v25.i29.3920 |
Ejemplares similares
-
Therapeutic challenge for immunotherapy targeting cold colorectal cancer: A narrative review
por: Ma, Shi-Xun, et al.
Publicado: (2023) -
Implication of gut microbiome in immunotherapy for colorectal cancer
por: Koustas, Evangelos, et al.
Publicado: (2022) -
Immunotherapy in biliary tract cancers: Current evidence and future perspectives
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2022) -
Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach
por: Valenzuela, Guillermo, et al.
Publicado: (2021) -
Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations
por: Guo, Songchuan, et al.
Publicado: (2017)